title: Combined immunotherapy and chemotherapy with tuftsin plus cyclophosphamide in the treatment of non-small-cell carcinoma of the lung.
authors.affiliation: Department of Clinical Oncology, Hadassah University Hospital, Jerusalem, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Warner
authors.forename: A
authors.initials: A
authors.lastname: Sulkes
authors.forename: E
authors.initials: E
authors.lastname: Gez
authors.forename: B
authors.initials: B
authors.lastname: Uziely
authors.forename: N
authors.initials: N
authors.lastname: Ben-Baruch
authors.forename: R
authors.initials: R
authors.lastname: Ben-Yosef
authors.forename: S
authors.initials: S
authors.lastname: Biran
authors.forename: R
authors.initials: R
authors.lastname: Catane
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D014405:Tuftsin / Q000627:therapeutic use*
chemical_list: D003520:Cyclophosphamide; D014405:Tuftsin